Hong Mu
Tianjin First Center Hospital(CN)Tianjin Medical University(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Protein Degradation and Inhibitors, Cell death mechanisms and regulation, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia(2013)726 cited
- → Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy(2017)303 cited
- → ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies(2016)199 cited
- → Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells(2016)169 cited
- → Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia(2016)122 cited
- → Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy(2015)111 cited